Ménard, Ludovic <br/><br/>
Reactivation of Mutant-EGFR Degradation through Clathrin Inhibition Overcomes Resistance to EGFR Tyrosine Kinase Inhibitors.  [electronic resource] 

 -  Cancer research  06 2018 
 - 3267-3279 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-17-2195  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Clathrin--antagonists & inhibitors<br/>Drug Resistance, Neoplasm--drug effects<br/>Endocytosis--drug effects<br/>ErbB Receptors--genetics<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Lysosomes--metabolism<br/>Mutation<br/>Protein Kinase Inhibitors--pharmacology<br/>Proteolysis--drug effects<br/>Signal Transduction--genetics<br/>Sulfonamides--pharmacology<br/>Thiazolidines--pharmacology